SPECKLIN; Jean-Luc
Patent Applications and Registrations
Patent applications and USPTO patent grants for SPECKLIN; Jean-Luc.The latest application filed is for "6-(buta-1,3-diyn-1-yl)benzo[d]thiazole derivatives".
Company Profile
3.20.23
- SPECKLIN; Jean-Luc - Allschwil CH
- Specklin; Jean-Luc - Kembs FR
- Specklin; Jean-Luc - Kembs-Schaeferhof FR
- Specklin; Jean-Luc - Kembs-Schaferhof FR
Patent Activity
| Patent | Date |
|---|---|
| 6-(buta-1,3-diyn-1-yl)benzo[d]thiazole Derivatives App 20190315731 - DIETHELM; Stefan ; et al. | 2019-10-17 |
| Substituted 1,2-dihydro-3H pyrrolo[1,2-c]imidazol-3 one antibacterials Grant 10,441,576 - Diethelm , et al. Oc | 2019-10-15 |
| Substituted 1,2-dihydro-3H-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds Grant 10,314,823 - Blumstein , et al. | 2019-06-11 |
| 1,2-dihydro-3H-pyrrolo[1,2-C]imidazol-3-one derivatives and their use as antibacterial agents Grant 10,106,544 - Chapoux , et al. October 23, 2 | 2018-10-23 |
| Crystalline forms of cadazolid Grant 10,087,171 - Hubschwerlen , et al. October 2, 2 | 2018-10-02 |
| SUBSTITUTED 1,2-DIHYDRO-3H-PYRROLO[1,2-c]IMIDAZOL-3-ONE ANTIBACTERIAL COMPOUNDS App 20180250273 - BLUMSTEIN; Anne-Catherine ; et al. | 2018-09-06 |
| SUBSTITUTED 1,2-DIHYDRO-3H PYRROLO[1,2-c]IMIDAZOL-3 ONE ANTIBACTERIALS App 20180235938 - DIETHELM; Stefan ; et al. | 2018-08-23 |
| Crystalline Forms Of Cadazolid App 20180179196 - HUBSCHWERLEN; Christian ; et al. | 2018-06-28 |
| Antibacterial Benzothiazole Derivatives App 20170355687 - CHAPOUX; Gaelle ; et al. | 2017-12-14 |
| 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one Derivatives And Their Use As Antibacterial Agents App 20170107223 - CHAPOUX; Gaelle ; et al. | 2017-04-20 |
| Antibacterial 1H-indazole and 1H-indole derivatives Grant 9,624,206 - Chapoux , et al. April 18, 2 | 2017-04-18 |
| Antibacterial 1h-indazole And 1h-indole Derivatives App 20170029411 - CHAPOUX; Gaelle ; et al. | 2017-02-02 |
| Oxazolidinone-quinolone Hybrid Antibiotics App 20150336992 - Hubschwerlen; Christian ; et al. | 2015-11-26 |
| Oxazolidinone-quinolone hybrid antibiotics Grant 9,133,213 - Hubschwerlen , et al. September 15, 2 | 2015-09-15 |
| Oxazolidinone-quinolone Hybrid Antibiotics App 20130296275 - Hubschwerlen; Christian ; et al. | 2013-11-07 |
| Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections Grant 8,513,231 - Hubschwerlen , et al. August 20, 2 | 2013-08-20 |
| Oxazolidinone-quinolone hybrid antibiotics Grant 8,501,774 - Hubschwerlen , et al. August 6, 2 | 2013-08-06 |
| Use Of Oxazolidinone-quinoline Hybrid Antibiotics For The Treatment Of Anthrax And Other Infections App 20120322766 - Hubschwerlen; Christian ; et al. | 2012-12-20 |
| Dual action antibiotics Grant 8,329,908 - Hubschwerlen , et al. December 11, 2 | 2012-12-11 |
| Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections Grant 8,268,812 - Hubschwerlen , et al. September 18, 2 | 2012-09-18 |
| Oxazolidinone-quinolone Hybrid Antibiotics App 20120142635 - Hubschwerlen; Christian ; et al. | 2012-06-07 |
| Use Of Oxazolidinone-quinoline Hybrid Antibiotics For The Treatment Of Anthrax And Other Infections App 20120135961 - Hubschwerlen; Christian ; et al. | 2012-05-31 |
| Oxazolidinone-quinolone hybrid antibiotics Grant 8,158,797 - Hubschwerlen , et al. April 17, 2 | 2012-04-17 |
| 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials Grant 8,124,623 - Hubschwerlen , et al. February 28, 2 | 2012-02-28 |
| Intermediate products for producing oxazolidinone-quinolone hybrids Grant 8,124,772 - Hubschwerlen , et al. February 28, 2 | 2012-02-28 |
| 5-hydroxymethyl-oxazolidin-2-one antibacterials Grant 8,039,466 - Hubschwerlen , et al. October 18, 2 | 2011-10-18 |
| Dual Action Antibiotics App 20110059946 - Hubschwerlen; Christian ; et al. | 2011-03-10 |
| Dual action antibiotics Grant 7,820,823 - Hubschwerlen , et al. October 26, 2 | 2010-10-26 |
| Novel Antibacterial Compounds App 20100222302 - Hubschwerlen; Christian ; et al. | 2010-09-02 |
| 5-hydroxymethyl-oxazolidin-2-one Antibacterials App 20100069376 - Hubschwerlen; Christian ; et al. | 2010-03-18 |
| Intermediate products for producing oxazolidinone-quinolone hybrids App 20090306389 - Hubschwerlen; Christian ; et al. | 2009-12-10 |
| 5-hydroxymethyl-oxazolidin-2-one-derivatives And Their Uses As Antibacterials App 20090247578 - HUBSCHWERLEN; Christian ; et al. | 2009-10-01 |
| Intermediate products for producing oxazolidinone-quinolone hybrids Grant 7,557,214 - Hubschwerlen , et al. July 7, 2 | 2009-07-07 |
| Oxazolidinone-Quinolone Hybrid Antibiotics App 20080027040 - Hubschwerlen; Christian ; et al. | 2008-01-31 |
| Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections App 20070155714 - Hubschwerlen; Christian ; et al. | 2007-07-05 |
| Intermediate products for producing oxazolidinone-quinolone hybrids App 20070004769 - Hubschwerlen; Christian ; et al. | 2007-01-04 |
| Piperazine derivatives Grant 7,022,707 - Adams , et al. April 4, 2 | 2006-04-04 |
| Dual action antibiotics App 20050096343 - Hubschwerlen, Christian ; et al. | 2005-05-05 |
| Novel piperazine derivatives App 20040235859 - Adams, David Reginald ; et al. | 2004-11-25 |
| Novel piperazine derivatives App 20020143020 - Adams, David Reginald ; et al. | 2002-10-03 |
| Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephams Grant 6,232,306 - Hebeisen , et al. May 15, 2 | 2001-05-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 